In summary, the GLP-1 receptor remains an interesting and noteworthy target for the pharmacotherapy of central nervous system diseases, not only those related to neurodegeneration and substance abuse, but GLP-1RA drugs may also prove effective as adjunctive therapies in the treatment of mood disorders such as depression
Dwyer M, Shan Q, Dortona S, Maurer R, Mitchell R, Olesen H, et al
Decongestants Decongestants like pseudoephedrine (Sudafed) and phenylephrine (Suphedrine PE) may help temporarily quell nasal congestion by constricting blood vessels, ultimately lessening swelling
Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, et al
However, Novo Nordisk argued that these versions are not FDA-approved and therefore pose safety risks to users, and subsequently filed over 100 lawsuits against the companies selling them